Skip to content

A clinical trial of Ayurvedic Formulations along with Yogic Practices in the management of Vatika Artavadushti w.s.r to Menstrual Disorder

The evaluation of Kashmarya-Kshudrasaha Ksheerapaka and Ashwagandha Ksheerapaka along with Yogic practices in the management of Vatika Artavadushti â?? A Single Blind Randomized Comparative Clinical study.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054021
Enrollment
30
Registered
2023-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients complaining of Vatika Artavadushti with any two of the following manifestations: a. Artava vaivarnya (Discolored Menstrual Blood) - Aruna varna (Red/Reddish Brown/Tawny) or Shyava varna (Dark Brown) or Krishna varna (Black). b. Alpa Artava (Hypomenorrhoea) c. Vicchinna 1) Interrupted pattern of menstrual cycle 2) Consistency of menstrual blood eg. Disintegrated / flaky d. Saruja Artava (Painful Menses) e. Artava Chiraat Nishichyate (Oligomenorrhoea). 2. Female patients of age group 12 â?? 45years

Exclusion criteria

Exclusion criteria: 1. Pregnant woman 2. Patient having any systemic disease. 3. Post menopausal woman. 4. Patient having any type of malignancy. 5. Patient having Sexually Transmitted Diseases. 6. Patient using oral contraceptive pills and Intra Uterine Contraceptive Devices. 7. Patient with thyroid hormone abnormalities. 8. Patient having any other Uterine or Pelvic pathology like â?? Polyp, Endometrial Tuberculosis, Fibroid, Adenomyosis, Pelvic Inflammatory Diseases, etc.

Design outcomes

Primary

MeasureTime frame
effect of therapy on Changes in the parameter of Vatika Artavadushti with sample size 30 Within 2 monthsTimepoint: 2 MONTHS

Secondary

MeasureTime frame
1. Changes in quality of life (WHOQOL-BREF) 2. Changes in stress level (Perceived stress scale) Timepoint: 2 months

Countries

India

Contacts

Public ContactDr HETAL H DAVE

National institute of ayurweda

hetaldave2406@gmail.com9251758867

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026